Trial Profile
A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Jun 2013
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Filgrastim
- Indications Ewing's sarcoma; Germ cell and embryonal neoplasms; Germ cell cancer; Glioma; Head and neck cancer; Neuroblastoma; Ovarian cancer; Sarcoma; Solid tumours; Wilms' tumour
- Focus Therapeutic Use
- 25 Feb 2013 New trial record